intravitreal anti-vascular endothelial growth factor use in France during COVID-19 pandemic

This study quantified changes in the use of   intravitreal (IVT) anti-vascular endothelial growth factors (anti-VEGF), the main treatment for retinal vascular abnormalities, since the COVID-19 pandemic started in France.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news